CD16/CD32 Monoclonal Antibody (93), eBioscience
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0460479
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $447.00
About this award
Life Technologies Corporation has been awarded a purchase order by the University of Virginia for the procurement of laboratory reagents. The contract, designated A207_PO-0460479, was awarded on August 1, 2026, with a cumulative contract value of $447. The prime contractor will deliver CD16/CD32 Monoclonal Antibody products manufactured by eBioscience, with an order quantity of 447 units at a unit price of $1 per item.
The line item specification calls for 447 units of CD16/CD32 Monoclonal Antibody, a commonly utilized research reagent in immunological and cellular analysis applications. Delivery is directed to the University of Virginia as the buyer and contracting organization. The contract represents a straightforward materials procurement in support of the university's research operations in Virginia.
Line items
| Item | Total |
|---|---|
| CD16/CD32 Monoclonal Antibody (93), eBioscience | $447.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0460479?
Contract A207_PO-0460479 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on August 1, 2026.
How much is contract A207_PO-0460479 worth?
Its cumulative value is $447.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award